Related Experiment Video
Updated: Feb 18, 2026

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.8K
Organizing and implementing a multidisciplinary fast track oncology clinic.
Y L Basta1,2, K M A J Tytgat1,2, H H Greuter3
1Department of Gastroenterology & Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
Summary
Implementing a fast track clinic (FTC) significantly reduced waiting times for gastrointestinal cancer patients. This model improved patient flow and care coordination without additional resources.
Area of Science:
- Oncology
- Health Services Research
- Healthcare Management
Background:
- Gastrointestinal malignancy patients require multidisciplinary care, often leading to sequential appointments and prolonged waiting times.
- Existing hospital structures can create bottlenecks, delaying diagnosis and treatment initiation.
Purpose of the Study:
- To evaluate the impact of a fast track clinic (FTC) on reducing waiting times for patients with gastrointestinal malignancies.
- To assess the effectiveness of a combined top-down and bottom-up implementation strategy for a new outpatient clinic model.
Main Methods:
- A fast track clinic (FTC) was established within the existing hospital framework, integrating patient-centered care principles.
- A hybrid implementation strategy combined a top-down mandate for interdepartmental cooperation and resource allocation with bottom-up physician-led brainstorming for operational planning.
- Care coordination was enhanced through specialist-led consultations, dedicated nurse coordinators, and consideration of patient preferences and comorbidities.
Main Results:
- Patient influx to the FTC tripled since its 2009 implementation.
- Average waiting time for initial appointments decreased from 2-4 weeks to 6 working days.
- Time from diagnosis to treatment initiation was reduced from 12-14 weeks to 17 working days.
- These improvements were achieved through resource reallocation without increasing overall hospital resources.
Conclusions:
- A combined top-down and bottom-up approach effectively facilitated interdepartmental collaboration and established a shared vision for patient-centered care.
- The FTC model enhances information exchange among specialists via co-location and a shared electronic health record.
- The FTC represents an organizational change that improves efficiency and patient outcomes within the existing hospital structure.
Related Concept Videos
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K

